Evolocumab Reduces MACE in Patients With and Without Multivessel CAD: FOURIER

The benefit in those with less atherosclerosis emerged late, highlighting the long-term benefits of LDL lowering.

Related Keywords

Boston ,Massachusetts ,United States ,Baylor College Of Medicine ,Texas ,Houston ,Vijay Nambi ,Marc Sabatine ,Layla Abushamat ,Sanofi Regeneron ,American College Of Cardiology Heart Association ,Amgen ,Journal Of The American College Cardiology ,American College ,American Heart Association ,Baylor College ,